Ian Kay
Impact in
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
Papers in
- Epidemiology 15
- Pneumonia and Respiratory Infections 7
- Respiratory viral infections research 4
-
- Antimicrobial Resistance in Staphylococcus 6
- Clostridium difficile and Clostridium perfringens research 3
- SARS-CoV-2 detection and testing 3
- Co-authors
- Silvano Palladino (15 shared papers)Todd M. Pryce (8 shared papers)Geoffrey W. Coombs (4 shared papers)James Flexman (13 shared papers)Grant Waterer (8 shared papers)Anna‐Maria Costa (1 shared paper)Christopher H. Heath (3 shared papers)Manel Luján (2 shared papers)
- Journals
- Diagnostic Microbiology and Infectious Disease (10 papers)Journal of Clinical Microbiology (2 papers)PLoS ONE (2 papers)Respirology (2 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- AustraliaUnited KingdomSpain
In The Last Decade
Ian Kay
28 papers receiving 984 citations
Peers
Comparison fields: 5 of 75
- Clinical Biochemistry 250
- Infectious Diseases 457
- Epidemiology 416
- Microbiology 77
- Applied Microbiology and Biotechnology 23
Countries citing papers authored by Ian Kay
This map shows the geographic impact of Ian Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Kay more than expected).
Fields of papers citing papers by Ian Kay
This network shows the impact of papers produced by Ian Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Kay. The network helps show where Ian Kay may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 154 | |
| 2 | 2009 | 150 | |
| 3 | 2005 | 93 | |
| 4 | 2006 | 92 | |
| 5 | 2003 | 70 | |
| 6 | 2004 | 65 | |
| 7 | 2003 | 55 | |
| 8 | 2003 | 53 | |
| 9 | 2003 | 34 | |
| 10 | 2018 | 33 | |
| 11 | 1995 | 31 | |
| 12 | 2001 | 30 | |
| 13 | 2008 | 28 | |
| 14 | 1999 | 21 | |
| 15 | 2014 | 19 | |
| 16 | 2001 | 18 | |
| 17 | 2017 | 16 | |
| 18 | 2011 | 15 | |
| 19 | 1997 | 11 | |
| 20 | 1996 | 6 |
About Ian Kay
Ian Kay is a scholar working on Epidemiology, Infectious Diseases, Clinical Biochemistry, Pulmonary and Respiratory Medicine and Microbiology, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Respiratory viral infections research (4 papers), Clostridium difficile and Clostridium perfringens research (3 papers), SARS-CoV-2 detection and testing (3 papers), Pleural and Pulmonary Diseases (3 papers) and Streptococcal Infections and Treatments (2 papers). The work is most often cited by research in Clinical Biochemistry (250 citations), Infectious Diseases (457 citations), Epidemiology (416 citations), Microbiology (77 citations) and Applied Microbiology and Biotechnology (23 citations). Ian Kay has collaborated with scholars based in Australia, United Kingdom and Spain. Frequent co-authors include Silvano Palladino, Todd M. Pryce, Geoffrey W. Coombs, James Flexman, Grant Waterer, Anna‐Maria Costa, Christopher H. Heath, Manel Luján, Jordi Rello and Thiago Lisboa. Their work appears in journals such as Diagnostic Microbiology and Infectious Disease, Journal of Clinical Microbiology, PLoS ONE, Respirology and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.